Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Shire Receives European Approval for Label Extension of CINRYZE to Prevent and Treat Hereditary Angi

americanpharmaceuticalreviewMarch 17, 2017

Tag: Pediatric Patients , Shire

PharmaSources Customer Service